Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04549116 · ClinicalTrials.gov registry record · Phase 3
Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.
A Phase 3 study of Infertility, sponsored by IBSA Institut Biochimique.
- Active
- Registry status
- Phase 3
- Development phase
- 680
- Enrollment target
- 20
- Study locations
NCT04549116 is a Phase 3 study of Infertility that is active but no longer recruiting, run by IBSA Institut Biochimique. The registered enrollment target is 680 participants, below the 7,580-participant average among 74 other Infertility trials with a reported enrollment target (91% lower). The trial reports 20 study locations across 12 states.
The verdict
NCT04549116, a Phase 3 study of Infertility, is active but no longer recruiting, sponsored by IBSA Institut Biochimique.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 680 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority clinical study in women aged 35 to 42 years. This study will investigate the safety and efficacy of Progesterone-IBSA to support euploid embryo blastocyst implantation and early pregnancy after frozen embryo transfer (FET) in a modified natural cycle as a treatment for infertile women. Subjects will be randomized to receive either active Progesterone-IBSA or Crinone 8% for luteal and early pregnancy support and these two groups will be compared.
Conditions Studied
Interventions
- DRUG Progesterone-IBSA Injectable Solution
- DRUG Progesterone Vaginal Gel with Applicator
- DRUG Placebo Vaginal gel with applicator
- DRUG Placebo injectable solution
Study Locations (20)
California
- HRC Fertility - Encino
- Kindbody - Los Angeles
- San Diego Fertility - San Diego
- Spring Fertility - San Francisco
Florida
- Women's Medical Research Group, LLC - Clearwater
- IVF Florida Reproductive Associates - Margate
- The IVF Center - Winter Park
North Carolina
- Reproductive Endocrinology Associates of Charlotte - Charlotte
- Carolina Conceptions - Raleigh
Pennsylvania
- Main Line Fertility - Bryn Mawr
- Shady Grove Fertility - Chesterbrook
Texas
- Care Fertility - Bedford
- Aspire Houston Fertility Institute - Houston
Arizona
- The Fertility Treatment Center, LLC - Tempe
Connecticut
- Illume Fertility - Norwalk
Delaware
- Reproductive Associates of Delaware - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 680 participants |
| Start Date | 2022-10-12 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04549116
The ClinicalTrials.gov registry entry for NCT04549116 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 680 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,580-participant average among 74 other Infertility trials with a reported enrollment target (91% lower). The listed sponsor is IBSA Institut Biochimique, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 4 interventions - of which Progesterone-IBSA Injectable Solution is the first listed.
NCT04549116 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Florida, North Carolina.
Frequently Asked Questions
What is clinical trial NCT04549116 about?
NCT04549116 is a clinical study titled "Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.". This is a multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority clinical study in women aged 35 to 42 years. This study will investigate the safety and efficacy of Progesterone-IBSA to support euploid embryo blastocyst implantation and early pregnancy after frozen e...
What is the current status of trial NCT04549116?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 680 participants. The study started on 2022-10-12. Estimated completion is 2026-06-30.
What conditions does trial NCT04549116 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT04549116?
The interventions under investigation include: Progesterone-IBSA Injectable Solution (DRUG), Progesterone Vaginal Gel with Applicator (DRUG), Placebo Vaginal gel with applicator (DRUG), Placebo injectable solution (DRUG).
Who is sponsoring clinical trial NCT04549116?
This trial is sponsored by IBSA Institut Biochimique, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04549116 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Delaware, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
RECRUITING · Phase 3
-
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
RECRUITING · Phase 3
-
Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation
COMPLETED · Phase 3
-
Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)
COMPLETED · Phase 3
-
A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
COMPLETED · Phase 3
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.